SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q4 2022 | $2,738 | -99.9% | 3,091,177 | +2.1% | 0.00% | -100.0% |
| Q3 2022 | $4,754,000 | -27.7% | 3,027,854 | -7.4% | 0.00% | 0.0% |
| Q2 2022 | $6,571,000 | -14.5% | 3,269,037 | -0.9% | 0.00% | 0.0% |
| Q1 2022 | $7,683,000 | -53.8% | 3,298,099 | -7.7% | 0.00% | -50.0% |
| Q4 2021 | $16,621,000 | -25.8% | 3,574,317 | +21.8% | 0.00% | -33.3% |
| Q3 2021 | $22,395,000 | -10.0% | 2,935,011 | +14.3% | 0.00% | 0.0% |
| Q2 2021 | $24,877,000 | +26.2% | 2,567,331 | +7.7% | 0.00% | 0.0% |
| Q1 2021 | $19,709,000 | +106.0% | 2,383,287 | +70.0% | 0.00% | +200.0% |
| Q4 2020 | $9,568,000 | +42.8% | 1,401,796 | +142.7% | 0.00% | 0.0% |
| Q3 2020 | $6,701,000 | +174.4% | 577,646 | +48.5% | 0.00% | – |
| Q2 2020 | $2,442,000 | +372.3% | 388,946 | +38.5% | 0.00% | – |
| Q1 2020 | $517,000 | +271.9% | 280,747 | +584.4% | 0.00% | – |
| Q4 2019 | $139,000 | +58.0% | 41,018 | 0.0% | 0.00% | – |
| Q3 2019 | $88,000 | -19.3% | 41,018 | +27.7% | 0.00% | – |
| Q2 2019 | $109,000 | -17.4% | 32,130 | +15.5% | 0.00% | – |
| Q1 2019 | $132,000 | +97.0% | 27,819 | -0.4% | 0.00% | – |
| Q4 2018 | $67,000 | -39.6% | 27,925 | +10.3% | 0.00% | – |
| Q3 2018 | $111,000 | -75.9% | 25,322 | -60.3% | 0.00% | – |
| Q2 2018 | $460,000 | +77.6% | 63,863 | -6.3% | 0.00% | – |
| Q4 2017 | $259,000 | +100.8% | 68,179 | -10.5% | 0.00% | – |
| Q3 2017 | $129,000 | +101.6% | 76,169 | +139.0% | 0.00% | – |
| Q2 2017 | $64,000 | +6300.0% | 31,875 | +17318.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 183 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -99.1% | 183 | -98.7% | 0.00% | – |
| Q3 2015 | $115,000 | -66.0% | 13,740 | -53.0% | 0.00% | – |
| Q1 2015 | $338,000 | -97.0% | 29,210 | -97.4% | 0.00% | -100.0% |
| Q4 2014 | $11,432,000 | +56.4% | 1,135,285 | -29.8% | 0.00% | +50.0% |
| Q3 2014 | $7,311,000 | -16.5% | 1,617,467 | +24.6% | 0.00% | 0.0% |
| Q2 2014 | $8,760,000 | -47.6% | 1,297,847 | -0.6% | 0.00% | -60.0% |
| Q1 2014 | $16,732,000 | +40.5% | 1,305,165 | -11.2% | 0.01% | +66.7% |
| Q4 2013 | $11,909,000 | – | 1,470,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |